Y. Tao, “Knockdown of GPRC5B alleviates the high glucose-induced inflammation and extracellular matrix deposition of podocyte through inhibiting NF-κB pathway”, Allergol Immunopathol, vol. 50, no. 2, pp. 142–146, Mar. 2022, doi: 10.15586/aei.v50i2.566.